Elevating Pharmacovigilance through Strategic Risk Communication | GCC PV Training 2026

How can safety communication become more useful, accessible and actionable? Explore highlights from the GCC Pharmacovigilance Training, held on 24–25 June 2026 in Dubai. This session examined communication as a central part of pharmacovigilance, drawing on the Abu Dhabi Pharmacovigilance Network (ADPVN) experience. Featuring: Dr. Lateefa Jamal Abdulla Al Marzooqi Section Head of Pharmacovigilance and Drug Education, Department of Health Abu Dhabi Moderated by: Dr. Michelle Gebara Patient Safety Lead for UAE & Gulf Countries, Roche Pharmaceuticals Part of our GCC Summit 2026 session highlights series. #GCCSummit2026 #GCCPharmacovigilanceTraining #Pharmacovigilance #RiskCommunication #PatientSafety